Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population PK/PD and individualized dosing of linezolid in prosthetic joint infection
ChiCTR2500112834Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of linezolid in periprosthetic joint infection (PJI), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: Serum concentration of linezolid and Synovial fluid concentration of linezolid. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
linezolid
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on ChiCTR2500112834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112834.